Clinical and genetic features of AGel amyloidosis caused by novel gelsolin variant and its impact on cardiac function and conduction disorders
Amyloid
.
2024 Dec 19:1-3.
doi: 10.1080/13506129.2024.2441784.
Online ahead of print.
Authors
A Roldán-Sevilla
1
,
M Gallego-Delgado
2
3
,
M T Lista-Araujo
4
,
J Torres-Pérez
5
,
A M Merino-Merino
1
,
C Gil-Polo
6
,
D Cantero-Lozano
7
,
S M Lorenzo-Hernandez
8
9
,
R Eiros-Bachiller
2
3
Affiliations
1
Inherited Cardiovascular Disease Unit, Cardiology Department, Burgos University Hospital, Spain.
2
Inherited Cardiovascular Disease Unit, Department of Cardiology, Complejo Asistencial Universitario de Salamanca, Spain.
3
CIBER Cardiovascular, Carlos III Health Institute, Madrid, Spain.
4
Pathological Anatomy Department, Burgos University Hospital, Burgos, Spain.
5
Anterior Ophthalmic Segment Unit, Ophthalmology Department, Burgos University Hospital, Burgos, Spain.
6
Neurology Department, Burgos University Hospital, Burgos, Spain.
7
Electrophisiology Unit, Cardiology Department, Burgos University Hospital, Spain.
8
Laboratory of Molecular Genetics. Clinical Analysis and Clinical Biochemistry Service, Complejo Asistencial Universitario de Salamanca, Spain.
9
Specific Reference Unit for Pharmacogenetics and Precision Medicine. Rare diseases Reference Unit of Castilla y León (DiERCyL) [AQ].
PMID:
39699273
DOI:
10.1080/13506129.2024.2441784
No abstract available